Triple-negative breast cancer brain metastasis: An update on druggable targets, current clinical trials, and future treatment options.
Saved in:
| Title: | Triple-negative breast cancer brain metastasis: An update on druggable targets, current clinical trials, and future treatment options. |
|---|---|
| Authors: | Nakhjavani M; School of Medicine, Deakin University, Geelong, VIC 3220, Australia; Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, VIC 3220, Australia. Electronic address: maryam.nakhjavani@deakin.edu.au., Samarasinghe RM; School of Medicine, Deakin University, Geelong, VIC 3220, Australia; Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, VIC 3220, Australia., Shigdar S; School of Medicine, Deakin University, Geelong, VIC 3220, Australia; Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, VIC 3220, Australia. |
| Source: | Drug discovery today [Drug Discov Today] 2022 May; Vol. 27 (5), pp. 1298-1314. Date of Electronic Publication: 2022 Jan 29. |
| Publication Type: | Journal Article; Review; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9604391 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-5832 (Electronic) Linking ISSN: 13596446 NLM ISO Abbreviation: Drug Discov Today Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1878-5832 |
|---|---|
| DOI: | 10.1016/j.drudis.2022.01.010 |
